BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201105T090000
DTEND;TZID=America/New_York:20201105T100000
DTSTAMP:20260403T183556
CREATED:20200916T174813Z
LAST-MODIFIED:20201013T200205Z
UID:4346-1604566800-1604570400@carb-x.org
SUMMARY:Antimicrobial Resistance Fighter Coalition Webinar: Aiming in the dark: what happens when disease spreads without diagnosis
DESCRIPTION:Panelists include Erin Duffy\, CARB-X Chief of R&D \nAMR in the Light of COVID-19 – A Webinar Series\nEach of us is now living in a world with a nearly untreatable virus – but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to kill them. COVID-19 foreshadows a grim future if we do not mobilize a global response to the growing threat of antimicrobial resistance (AMR). Through a four-part series\, global experts will discuss how the COVID-19 pandemic could reshape strategies for combating antimicrobial resistance around the world. \nAbout this Webinar:\nThe pandemic has demonstrated the critical role of diagnostic testing to steer our public health response. It has been shown that diagnostic testing for bacterial and fungal infections results in improved use of antibiotics and antibiotic stewardship. But whereas testing for COVID-19 has benefited from innovation and rapid uptake\, testing for drug resistant infections remains underutilized. How can we improve the effective use of diagnostics\, globally\, for the diagnosis of bacterial and viral infections? \nTo learn more about the Antimicrobial Resistance Fighter Coalition\, click here.\nTo learn more about this webinar series\, click here.\nTo register for this webinar\, click here.
URL:https://carb-x.org/event/antimicrobial-resistance-fighter-coalition-webinar-aiming-in-the-dark-what-happens-when-disease-spreads-without-diagnosis/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201116
DTEND;VALUE=DATE:20201117
DTSTAMP:20260403T183556
CREATED:20201013T201730Z
LAST-MODIFIED:20201013T201930Z
UID:4460-1605484800-1605571199@carb-x.org
SUMMARY:FDA Public Workshop: Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial New Animal Drugs
DESCRIPTION:The Food and Drug Administration (FDA\, the Agency\, or we) is hosting a virtual public meeting entitled “Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial New Animal Drugs.” The purpose of the meeting is to obtain early input from the public on a potential revised approach for considering the human medical importance of antimicrobial new animal drugs when assessing and managing the antimicrobial resistance risks associated with the use of antimicrobial drugs in animals. The Agency is seeking public input on a potential revised process for ranking antimicrobials according to their relative importance in human medicine\, on the potential criteria for their ranking\, and on the resulting ranked list of antimicrobial drugs. A concept paper describing this potential revised process will be made available for discussion at the public meeting. \nClick here to learn more.\nClick here for the concept paper posted in advance of the meeting.
URL:https://carb-x.org/event/fda-public-workshop-potential-approach-for-ranking-of-antimicrobial-drugs-according-to-their-importance-in-human-medicine-a-risk-management-tool-for-antimicrobial-new-animal-drugs/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201117T100000
DTEND;TZID=America/New_York:20201117T110000
DTSTAMP:20260403T183556
CREATED:20201104T141806Z
LAST-MODIFIED:20201110T151145Z
UID:4546-1605607200-1605610800@carb-x.org
SUMMARY:CARB-X WEBINAR: Tackling Drug-resistant Bacteria: Exciting Science in the CARB-X Portfolio - Vedanta\, Eligo\, Peptilogics
DESCRIPTION:Join us Tuesday\, November 17\, at 10 AM – 11 AM ET for an update on CARB-X\, and an insider’s look at 3 innovative programs supported by CARB-X \nCARB-X is hosting this special webinar to showcase some of the exciting science in the CARB-X portfolio and the progress CARB-X is making supporting the development of innovative therapeutics\, preventatives and rapid diagnostics to address antibiotic-resistant bacteria. \nThe webinar will be moderated by Kevin Outterson\, Executive Director of CARB-X\, and will feature \n\nErin Duffy\, CARB-X R&D Chief\, on portfolio priorities and progress\nXavier Duportet\, Co-Founder and CEO of Eligo Bioscience\, on Eligo’s innovative CRISPR-based therapeutics derived from bacteriophages to prevent and treat antibiotic-resistant infections in transplant patients\nJonathan Steckbeck\, Founder and CEO of Peptilogics\, on the development of their first-in-class antibiotic peptide for the treatment of prosthetic joint infections which recently was granted Orphan Drug Designation by the US Food and Drug Administration\nBernat Olle\, Co-Founder and CEO of Vedanta Biosciences\, on Vedanta’s microbiome program\, including VE707\, an oral therapeutic designed to restore a patient’s healthy microbiota to that it can fight multidrug-resistant bacteria\, and VE303\, which has recently become the first CARB-X-funded therapeutic to go on to secure BARDA support for late-stage development\, and is also the first-ever BARDA award for research and development of a live bio-therapeutic product.\n\nA virtual Q&A will also be held. \nCLICK HERE TO REGISTER TODAY:\nOnce you register\, you will receive a confirmation and will be able to download an invitation to your calendar.
URL:https://carb-x.org/event/carb-x-webinar-tackling-drug-resistant-bacteria-exciting-science-in-the-carb-x-portfolio/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201117T110000
DTEND;TZID=America/New_York:20201117T123000
DTSTAMP:20260403T183556
CREATED:20201026T143033Z
LAST-MODIFIED:20201026T143155Z
UID:4511-1605610800-1605616200@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE – Discovery of new antibacterials using artificial intelligence (computational chemoinformatics)
DESCRIPTION:Speakers: \n\nJames J. Collins\, Termeer Professor of Medical Engineering & Science Professor\, Broad Institute of MIT and Harvard (USA)\nCesar de la Fuente\, Presidential Assistant Professor\, University of Pennsylvania (USA)\nHenriette Willems\, Senior Research Associate\, The ALBORADA Drug Discovery Institute\, University of Cambridge\, (UK)\nFredrik Svensson\, Senior Research Associate\, UCL Drug Discovery Institute\, London\, (UK)\n\nModerator:  \n\nLaura Piddock\, Director of Scientific Affairs\, GARDP\n\nIn this webinar\, the speakers will give an overview of their work on the discovery of antibiotics through the use of artificial intelligence. The session will include the following presentations: \n\nDeep learning approaches to antibiotic discovery – James J. Collins\nAntibiotic discovery by means of computers – Cesar de la Fuente\nComputational Chemistry on a Budget – Henriette Willems & Fredrik Svensson\n\nTo learn more\, click here. 
URL:https://carb-x.org/event/live-webinar-gardp-revive-discovery-of-new-antibacterials-using-artificial-intelligence-computational-chemoinformatics/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201118
DTEND;VALUE=DATE:20201125
DTSTAMP:20260403T183556
CREATED:20201110T184941Z
LAST-MODIFIED:20201110T184941Z
UID:4564-1605657600-1606262399@carb-x.org
SUMMARY:World Antimicrobial Awareness Week 2020
DESCRIPTION:The theme for World Antimicrobial Awareness Week 2020 for the human health sector is “United to preserve antimicrobials.” \nEvery year\, World Antimicrobial Awareness Week aims to increase awareness of global antimicrobial resistance (AMR) and to encourage best practices among the general public\, health workers and policy makers to stop the further emergence and spread of drug-resistant infections. \nWAAW has expanded its scope to address not just antibiotics\, but all antimicrobials\, including antiviral\, antifungal and antiparasitic medicines. This exciting decision came on the strong recommendation of the antimicrobial resistance (AMR) community. In the midst of a global pandemic\, stakeholders came together virtually to discuss the challenges and opportunities for the WAAW campaign and awareness of Antimicrobial Resistance (AMR) more generally. The overarching message was that all sectors needed to unite to change behaviours and that the campaign needed to broaden its scope from antibiotics\, to include all antimicrobials. \nFor the first time ever\, we are also celebrating WAAW at a time when traditional methods of campaigning are not possible. We are challenged by new rules of social distancing\, limitations on public gatherings\, and physical isolation. As with the global virtual consultation in May 2020\, however\, the AMR community has shown its commitment\, resilience and eagerness to celebrate\, unite\, and build awareness around an issue that is becoming one of the most significant challenges to our global health and development objectives. Over the 7 days of WAAW 2020\, events will be held virtually in all regions of the world\, by governments\, academics\, students\, health care workers\, NGOs and all those interested and passionate about combating AMR. \nTo learn more\, click here.
URL:https://carb-x.org/event/world-antimicrobial-awareness-week-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20201118T093000
DTEND;TZID=Europe/Amsterdam:20201118T174500
DTSTAMP:20260403T183556
CREATED:20201110T160522Z
LAST-MODIFIED:20201112T205559Z
UID:4561-1605691800-1605721500@carb-x.org
SUMMARY:Emerging Antimicrobials and Diagnostics in AMR 2020
DESCRIPTION:CARB-X participants include Nadia Cohen\, Alliance Manager\, who will present during the Accelerating AMR R&D section of the program at 10:40 EST\, and Betsy Wonderly Trainor\, Alliance Director\, who will present at 10:20 EST. \nLearn about the latest AMR technologies in a series of interactive key note lectures by international Captains of Industry and Leading Scientists. \nInteractive\, one day online event providing an international podium for emerging preventives\, antimicrobial strategies\, microbial diagnostics and related (platform) technologies: key note lectures\, technology and product updates\, frontline stories and concluding Q&A session. \nThe event is composed of 3 building sections:\nI: Setting the scene of AMR R&D (09:30 – 12:30 AM)\nII: Technology and Product Updates in AMR (01:00 – 03:50 PM)\nIII: Accelerating AMR R&D (04:00 – 05:45 PM). \nDate: 18 November\, 2020; 09:30 AM – 05:45 PM CET\nThe event is delivered digitally in collaboration with KIT Royal Tropical Institute in Amsterdam and marks the beginning of the World Antimicrobials Awareness Week. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/emerging-antimicrobials-and-diagnostics-in-amr-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201118T100000
DTEND;TZID=America/New_York:20201118T110000
DTSTAMP:20260403T183556
CREATED:20201116T145029Z
LAST-MODIFIED:20201116T145029Z
UID:4582-1605693600-1605697200@carb-x.org
SUMMARY:Wellcome Trust Webinar: The Global Response to drug-resistant infections - momentum\, success and critical gaps
DESCRIPTION:Over the last year\, Wellcome has mapped the global response to AMR to identify progress made since the UN High-Level Meeting on AMR held in 2016.  The analysis captures the views of over 150 experts and reviewed more than 250 documents and aims to bring all this together in a critical path for what the global response to AMR could look like now\, and beyond 2030. \nRecognizing the impact of Covid-19\, the work was expanded to understand if the pandemic has changed how we position efforts to address AMR. The work has been critical in informing Wellcome’s strategic approach toward ending drug-resistant infections and we hope it will benefit other stakeholders by helping to inform where urgent focus is needed. \nJoin us for the launch of this important piece of work\, reflect on what it means to you and your work and hear the reactions of others. \nYou can download the full report here.  \nTo learn more\, click here.\nTo view the agenda\, click here.\nTo register\, click here. \n  \nThe meeting will start at 3PM GMT / 10AM EST
URL:https://carb-x.org/event/wellcome-trust-webinar-the-global-response-to-drug-resistant-infections-momentum-success-and-critical-gaps/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201119T090000
DTEND;TZID=America/New_York:20201119T100000
DTSTAMP:20260403T183556
CREATED:20200924T151233Z
LAST-MODIFIED:20200924T151233Z
UID:4408-1605776400-1605780000@carb-x.org
SUMMARY:Antimicrobial Resistance Fighter Coalition Webinar: Responding to difficult-to-treat infections: Role and responsibilities of governments\, researchers\, clinicians\, industry and patients
DESCRIPTION:AMR in the Light of COVID-19 – A Webinar Series\nEach of us is now living in a world with a nearly untreatable virus – but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to kill them. COVID-19 foreshadows a grim future if we do not mobilize a global response to the growing threat of antimicrobial resistance (AMR). Through a four-part series\, global experts will discuss how the COVID-19 pandemic could reshape strategies for combating antimicrobial resistance around the world. \nAbout this Webinar:\nGovernments\, researchers\, and industry partners around the world have mobilized to develop diagnostics\, therapeutics\, and vaccines for COVID-19. The development of new recommendations and practices continue to be deployed to slow the spread of COVID-19. The burden of drug-resistant infections could surpass COVID-19. Drugs like antibiotics are a vital tool for modern medicine\, used to prevent and treat infections. As drug-resistant infections are becoming more common\, modern medicine as we know it is at risk and much like COVID-19\, it has the potential to overwhelm our healthcare structure. What changes are needed to reshape strategies for combatting antimicrobial resistance globally? \nTo learn more about the Antimicrobial Resistance Fighter Coalition\, click here.\nTo learn more about this webinar series\, click here.\nTo register for this webinar\, click here.
URL:https://carb-x.org/event/antimicrobial-resistance-fighter-coalition-webinar-responding-to-difficult-to-treat-infections-role-and-responsibilities-of-governments-researchers-clinicians-industry-and-patients-2/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201120T043000
DTEND;TZID=America/New_York:20201120T060000
DTSTAMP:20260403T183556
CREATED:20201026T142835Z
LAST-MODIFIED:20201026T142835Z
UID:4510-1605846600-1605852000@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE – Saving childrens’ lives – treating neonatal sepsis
DESCRIPTION:Speakers: \n\nProf Hanan Balkhy\, Assistant Director-General for Antimicrobial resistance\, WHO\nDr Manica Balasegaram\, Executive Director\, GARDP – Dr Dhanya Dharmapalan\, paediatrician and member of the Pediatric Infectious Disease Society (PIDS)\, Mumbai\nDr Borna Nyaoke\, Senior Clinical Project Manager\, DNDi/GARDP Kenya\n\nModerator:  \n\nDr Peter Beyer\, Senior Advisor\, AMR Division\, WHO The presentations will be followed by a Q&A session.\n\nThe webinar\, organized in collaboration with WHO\, is being held on the occasion of Universal Children’s Day and during World Antimicrobial Awareness Week. It will focus on the challenges in treating newborns suffering from drug-resistant sepsis and finding new treatment options. \nTo learn more\, click here. 
URL:https://carb-x.org/event/live-webinar-gardp-revive-saving-childrens-lives-treating-neonatal-sepsis-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201130
DTEND;VALUE=DATE:20201204
DTSTAMP:20260403T183556
CREATED:20200924T152007Z
LAST-MODIFIED:20200924T152007Z
UID:4410-1606694400-1607039999@carb-x.org
SUMMARY:World Vaccine and Immunotherapy Congress West Coast 2020
DESCRIPTION:In December 2019 SARS-CoV-2 the cause of COVID-19\, was responsible for thousands of deaths in Wuhan\, China. By March 11\, 2020\, WHO declared COVID-19 as a worldwide pandemic.The single most effective way to tackle this pandemic is a working vaccine\, which is why Vaccine Congress West Coast is bringing together experts who have been working tirelessly to make this happen\, in a safe\, virtual environment. This is the most important meeting you will be part of. Now more than ever\, we need everyone’s contribution to solve this global problem. \nCome together and join us VIRTUALLY to identify the urgent priorities for research. To mobilize\, coordinate and align funding to enable the research needed to tackle this crisis and stop the outbreak\, and commit with our experts how you can learn mechanisms for continuing scientific interactions and collaborations\, now and beyond the congress. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/world-vaccine-and-immunotherapy-congress-west-coast-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
END:VCALENDAR